Submitted by: Submitted by sankp
Views: 10
Words: 430
Pages: 2
Category: Business and Industry
Date Submitted: 05/11/2016 12:06 AM
Retinoblastoma Market Share, Size, Syndrome, Treatment, Symptoms, Analysis, Pipeline Review, H2 2015
Global Markets Direct's, 'Retinoblastoma - Pipeline Review, H2 2015', provides an overview of the Retinoblastoma's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Retinoblastoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Retinoblastoma and special features on late-stage and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/retinoblastoma-pipeline-review-h2-2015
Reasons To Buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Retinoblastoma
Table Of Content
Table Of Contents 2
List of Tables 4
Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Retinoblastoma Overview 6
Therapeutics Development 7
Pipeline Products for Retinoblastoma - Overview 7
Pipeline Products for Retinoblastoma - Comparative Analysis 8
Retinoblastoma - Therapeutics under Development by Companies 9
Retinoblastoma - Therapeutics under Investigation by Universities/Institutes 10
Retinoblastoma - Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Retinoblastoma - Products under Development by...